Altin Met 50mg/850mg Tablets (14s)

Description

Altin-Met is a prescription combination tablet containing vildagliptin and metformin hydrochloride for improving blood-glucose control in adults with type 2 diabetes mellitus. It is used with dietary management and physical activity, alone or with other antihyperglycemic treatment when prescribed.

• Manufacturer Name: LCI Pakistan
• Drug Class: DPP-4 inhibitor plus biguanide antihyperglycemic
• Dosage Form: Immediate-Release Tablet
• Storage: Store at room temperature in a dry place, protected from heat, moisture, and direct light. Keep out of reach of children and keep the tablets in their original packaging.
• Pack Size: Pack of 14 Tablets

Ingredients

• Vildagliptin 50 mg
• Metformin hydrochloride 850 mg

Benefits

• Improves blood-glucose control in adults with type 2 diabetes mellitus.
• Used with diet and exercise when lifestyle measures alone are insufficient.
• May be used alone or with other prescribed diabetes medicines, including insulin or a sulfonylurea.

Usage & Safety

For Adult

• Use only as directed by a physician; the dose is individualized according to previous treatment, blood-glucose control, kidney function, and tolerability.
• This 50 mg/850 mg combination is commonly taken as one tablet twice daily with meals, when prescribed as a twice-daily regimen.
• Take with food to reduce stomach upset and swallow the tablet whole with water; do not crush or chew unless specifically instructed.
• Monitor blood glucose and follow the prescribed diet and exercise plan.

For Children

• Safety and effectiveness have not been established in children and adolescents below 18 years.
• Not recommended for pediatric use unless specifically directed by a specialist.
• No standard pediatric weight-based dose or minimum weight limit is established.

Side Effects

• Common effects include nausea, diarrhea, abdominal discomfort, indigestion, vomiting, reduced appetite, headache, and altered taste.
• Metformin may reduce vitamin B12 absorption during prolonged use.
• Low blood glucose is more likely when used with insulin or sulfonylureas.
• Vildagliptin may cause elevated liver enzymes; rarely, hepatitis or other liver injury may occur.
• Rare but serious effects include pancreatitis, severe allergic reactions, skin or blistering reactions, and metformin-associated lactic acidosis.
• Report severe or persistent abdominal pain, yellowing of the skin or eyes, facial swelling, breathing difficulty, or symptoms of lactic acidosis immediately.

Contraindications

• Do not use in patients with allergy to vildagliptin, metformin, or any tablet ingredient.
• Contraindicated in diabetic ketoacidosis, diabetic precoma, or metabolic acidosis.
• Do not use in severe kidney impairment or when kidney function is unsuitable for metformin therapy.
• Generally contraindicated in significant hepatic impairment or active liver disease; liver function should be assessed as clinically appropriate.
• Use is unsuitable in acute conditions that may cause dehydration, severe infection, hypoxia, heart or respiratory failure, or reduced kidney function.
• Temporarily discontinue around iodinated contrast procedures or major surgery when advised by the treating clinician.
• Seek urgent medical advice for persistent vomiting, severe abdominal pain, unusual muscle pain, marked weakness, breathing difficulty, or extreme drowsiness.

Precautions & Warnings

• Alcohol increases the risk of metformin-associated lactic acidosis and should be avoided or minimized.
• Iodinated contrast agents may worsen kidney function and increase lactic-acidosis risk; metformin may need to be withheld before and after contrast administration.
• Insulin, sulfonylureas, and other glucose-lowering medicines may increase the risk of hypoglycemia; dose adjustment may be required.
• Medicines that affect kidney function or metformin clearance, including some diuretics, antihypertensives, and cationic medicines, require medical review.
• Corticosteroids, thyroid medicines, sympathomimetics, and some diuretics may alter blood-glucose control.
• Tell the prescriber about all prescription medicines, over-the-counter products, and herbal supplements before starting treatment.

Pregnancy

• Discuss pregnancy, planned pregnancy, or inadequate contraception with the treating physician before use.
• Safety data for the vildagliptin/metformin combination in pregnancy are limited; it should be used during pregnancy only when specifically prescribed.
• Insulin is often preferred when medication is required for diabetes control during pregnancy, according to clinical assessment.
• Breastfeeding use should be discussed with a physician because evidence for vildagliptin transfer into human milk is limited; an alternative may be recommended.

Altin Met 50mg/850mg Tablets (14s) Available Online in Pakistan

Dwatson offers Altin Met 50mg/850mg Tablets (14s) at Rs.500, with fast, discreet delivery across Pakistan.